findmyKOL
Clinical trialNCT01272531CompletedObservational

Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)

SponsorUniversity of California, San DiegoEnrollment560Bipolar Affective Disorder
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a prospective pharmacogenomics study of mood stabilizer response. The goal of this work is to identify genes associated with good response of patients with bipolar disorder to two commonly used mood stabilizing agents, lithium and valproate.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Dalhousie University

    Halifax, Nova Scotia, Canada

Norway
  • University of Bergen

    Bergen, Norway

United States
  • University of California San Diego

    San Diego, California, United States

  • University of Chicago

    Chicago, Illinois, United States

  • Indiana University

    Indianapolis, Indiana, United States

  • University of Iowa

    Iowa City, Iowa, United States

  • Johns Hopkins Hospital

    Baltimore, Maryland, United States

  • University of Michigan

    Ann Arbor, Michigan, United States

  • University Hospitals Case Medical Center

    Cleveland, Ohio, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Mood stabilizer treatment
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2011
Primary completion
30 Apr 2016
Completion
30 Apr 2016
Last update posted
9 Jun 2020
Registered enrollment
560
Registry id
NCT01272531

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.